Author

Mari N. Nakamura

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:imaging· 1 Assay:metabolomics· 1

Frequent Co-Authors

Aikaterini ZiogouiD· 1 shared Alec J. VaughaniD· 1 shared David B. ShackelfordiD· 1 shared Diane M. SimeoneiD· 1 shared Jozef P. BossowskiiD· 1 shared Katherine WuiD· 1 shared Lidong WangiD· 1 shared Marcus ConradiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aikaterini ZiogouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting FSP1 triggers ferroptosis in lung cancer

Katherine Wu, Alec J. Vaughan, Jozef P. Bossowski, Yuan Hao, Aikaterini Ziogou, Seon Min Kim, Tae Ha Kim, Mari N. Nakamura, Ray Pillai, Mariana Camargo Silva Mancini, Sahith Rajalingam, Mingqi Han, Toshitaka Nakamura, Lidong Wang, Suckwoo Chung, , Thales Y. Papagiannakopoulos

Genetic deletion or pharmacological inhibition of ferroptosis suppressor protein 1 (FSP1) induces lipid peroxidation and restricts lung adenocarcinoma growth in vivo, establishing FSP1 as a therapeutic vulnerability.

Nature · Nov 5, 2025Peer-reviewedCancer Biology✦ In-depth digest